EL7.AI
StocksMedium•19 November 2026•
4 min read

Endava Confirms Annual Report Delay, Estimates Revenue Reduction of About 2–4%

Key Facts

1Endava told the Securities and Exchange Commission on 3 November 2026 that it could not file its annual report by the deadline.
2The annual report filing deadline was 2 November 2026.
3The company initially estimated a revenue reduction of about 2–4% of fiscal 2025 revenue.
4Management expects to report one or more material weaknesses in internal controls.

Endava told the U.S. Securities and Exchange Commission on 3 November 2026 that it would be unable to file its annual report on Form 20-F for the fiscal year ended 30 June 2026 by the deadline. The company said the filing was due on 2 November and that it could not meet the deadline without unreasonable effort or expense. Its disclosure links the delay to the investigation and restatement of affected periods, as well as leadership changes and ongoing external audit procedures. The disclosure confirms the late filing and notice to the SEC; it does not establish that the New York Stock Exchange sent the company a non-compliance notice. The confirmed development, therefore, is that the company could not file its report on time as it works to determine the investigation’s impact on its financial results.

Endava said its audit committee identified financial periods whose results should no longer be relied upon, including the quarter ended 30 September 2025. The periods extend to the three and six months ended 31 December 2025, followed by the three and nine months ended 31 March 2026. This time frame means the review covers more than a single quarter and includes quarterly, half-year and nine-month data. The company said some agreements with parties that were both customers and suppliers either lacked economic substance or had terms and pricing negotiated as a single arrangement. It said the related revenue and balance-sheet entries did not comply with applicable accounting standards, requiring it to revisit the published periods.

The company initially estimated that the revenue reduction related to the affected periods and reflected in fiscal 2026 would equal about 2–4% of prior fiscal 2025 revenue. The estimate compares the expected accounting treatment’s impact with revenue in the previous fiscal year, but is not a final reported figure for 2026 revenue. Endava also said the restatement would include non-cash adjustments to some balance-sheet accounts, including goodwill and intangible assets. It said those adjustments would include the impact of revenue adjustments and reduce adjusted profit before tax. The review’s effects, according to the company’s disclosure, therefore extend from revenue recognition to balance-sheet accounts and adjusted profitability.

On internal controls, management said it expects to report one or more material weaknesses in internal control over financial reporting in the fiscal 2026 annual report. The expected disclosure comes amid a review of accounting entries related to agreements with parties that served as both customer and supplier. The company’s response to the investigation has included leadership changes: Chief Financial Officer Mark Thurston resigned from both of his positions, effective 25 October 2026. General Counsel Rohit Bhoothalingam also resigned, effective 26 October, while Rob Machin was scheduled to become interim chief executive on 2 November. The company places these changes among the developments surrounding the investigation, restatement of results and ongoing external audit procedures.

Endava withdrew the financial guidance it had previously issued for the fourth quarter and fiscal 2026, saying it should no longer be relied upon following the investigation and restatement. That means the guidance no longer represents the company’s approved expectations for the period while its review of the affected figures remains incomplete. The company did not set a date for announcing fourth-quarter and fiscal 2026 results, but said it would announce the timing when practicable. It also said it would inform investors of the fiscal 2027 first-quarter results schedule after filing the annual report. The company also linked the delay to ongoing external audit procedures, without setting a final filing deadline in its disclosure.

Endava said its remediation plan would include changes to accounting and reporting procedures, hiring additional qualified finance staff, and adopting enhanced governance and training. The company said these steps are intended to address the accounting and control issues that emerged during the investigation. Regarding the stock’s listing, the New York Stock Exchange says its official list includes companies late with annual or interim reports, but the list page available at the time of review showed no non-compliant or late filers. Endava’s available disclosure does not establish that the exchange issued a notice to the company or threatened to delist it. The next steps announced remain completion of the audit procedures and restatement, followed by filing the report and announcing results dates, as the company said.

Open on chart